Can You Take a GLP-1 and HRT Together? What Current Labels Say

If you're in your 40s or 50s and trying to lose weight, there's a good chance someone has mentioned GLP-1 medications. Ozempic. Wegovy. Mounjaro. Zepbound. They are, at this point, impossible to avoid in any conversation about midlife weight. And if you're also in perimenopause or menopause and thinking about HRT, or already on it, you probably have questions. Can you take both? Do they interact? Does menopause change how GLP-1s work? Does HRT affect the weight loss?

The honest answer is that we are still learning. GLP-1 medications became widely used before there was much research on how they work in menopausal women specifically. This page separates what the drug labels actually say from what is still unknown.

Can you take HRT and a GLP-1 together?

Current US labels for semaglutide (Ozempic, Wegovy, Rybelsus) and tirzepatide (Mounjaro, Zepbound) do not list menopausal hormone therapy as a combination to avoid. Both medicines slow stomach emptying, which can change how some pills are absorbed, but their effect on oral menopausal estradiol or progesterone has not been established. Tirzepatide's labels tell women on birth control pills to switch to a non-oral method or add a barrier method for 4 weeks after starting and after each dose increase. That instruction is about contraception, not menopausal HRT.

If you take any part of your HRT by mouth, ask your prescriber whether your regimen should be reviewed when you start a GLP-1 or increase the dose, and make sure everyone prescribing for you knows about both medicines.

What the labels say about oral medicines

These labels all note that slower stomach emptying has the potential to affect how other medicines taken by mouth are absorbed. Where they differ is on birth control pills:

• Semaglutide (Ozempic, Wegovy, Rybelsus). No backup-contraception instruction.
• Tirzepatide (Mounjaro, Zepbound). Women using oral hormonal contraceptives are told to switch to a non-oral method or add a barrier method for 4 weeks after starting and for 4 weeks after each dose increase. Non-oral hormonal contraceptives should not be affected.
• Orforglipron (Foundayo), a newer GLP-1 taken as a daily pill. Its label gives a similar instruction for 30 days after starting and after each dose increase, and says its effect on oral contraceptives has not been evaluated in a clinical trial.

None of these instructions is about menopausal HRT. A finding about birth control pills does not tell you what happens to oral estradiol or progesterone, in either direction. For semaglutide and tirzepatide, the British Menopause Society says the effect on oral HRT is unknown.

Does it matter whether my HRT is a pill or a patch?

Estrogen patches, gels and sprays are absorbed through the skin, so they do not depend on the stomach. That is a reason to expect them to be less exposed to this question, but it is reasoning from how the medicine is delivered, not a study of the combination.

A patch also does not settle the rest of the regimen. If you use systemic estrogen and still have a uterus, you need a progestogen to protect the uterine lining. One common option, micronized progesterone, is a capsule taken by mouth. Some women instead use a 52 mg levonorgestrel IUD such as Mirena, which the British Menopause Society supports for up to five years of endometrial protection; in the US that use is off-label (see using Mirena with HRT). Ask how your full regimen provides that protection while you are on a GLP-1.

Are side effects worse when you take both?

Each treatment has its own side effects, and current evidence does not show whether using them together makes those effects more likely or more severe. Nausea and other stomach side effects are common when starting a GLP-1 or increasing the dose.

One 2025 case report described a 51-year-old woman on oral estrogen whose hot flashes and mood worsened while her semaglutide dose was being increased, and settled when the increase was slowed. The author suggested reduced estrogen absorption as a possible explanation. A single case cannot show that, but it is a reason to tell your prescriber if menopause symptoms return after a dose change.

A quick refresher on how GLP-1s work

Semaglutide (Ozempic, Wegovy, Rybelsus) activates the GLP-1 receptor, mimicking a hormone your gut releases after eating. Tirzepatide (Mounjaro, Zepbound) activates both the GIP and GLP-1 receptors. They slow stomach emptying, reduce appetite, and improve blood sugar control. For many people, this adds up to significant weight loss.

Both were first developed for type 2 diabetes. Wegovy (an injection and, since December 2025, a tablet) and Zepbound are FDA-approved for weight management, while Ozempic, Mounjaro and Rybelsus carry type 2 diabetes indications. Orforglipron (Foundayo), a once-daily pill, is also approved for weight management; our Foundayo guide covers what its label says.

How menopause complicates the weight loss picture

The Menopause Society describes midlife weight gain as the result of several things at once: aging, hormone-related changes in where the body stores fat, sleep, activity and eating patterns. Menopause does not make diet and exercise ineffective, even when the same habits seem to deliver less than they used to.

That is part of why GLP-1 medicines draw so much interest in midlife. They were not developed as menopause treatments, though, and a 2026 expert review by the Spanish Menopause Society describes the menopause-specific evidence as limited and largely observational.

Does HRT make GLP-1s work better?

Two retrospective studies from Mayo Clinic researchers found that postmenopausal women using hormone therapy lost more weight, on average, while taking a GLP-1 medicine. In the semaglutide study, published in 2024, the 16 women on hormone therapy lost about 16% of their body weight at 12 months, against about 12% for the 90 women who were not. A 2026 study of 120 matched postmenopausal women taking tirzepatide found a similar pattern: 19.2% average weight loss with systemic hormone therapy, against 14.0% without.

Neither study assigned women to hormone therapy at random, so they show an association, not that HRT makes the medicine work better. Researchers have proposed metabolic explanations, but these studies did not test them, and they did not test starting HRT to improve a GLP-1's results. Hormone therapy is not indicated as a weight-loss treatment on its own.

Does menopause change how GLP-1s work?

A post hoc analysis of the tirzepatide trials found more weight loss with tirzepatide than with placebo in women before, during and after menopause. It was not designed to show whether menopause changes the response to every GLP-1 medicine. What menopause does change is what else is worth planning for:

• Muscle. Weight lost on these medicines can include muscle as well as fat. Ask how protein intake and resistance exercise can help you keep muscle during treatment.
• Bone. Bone loss speeds up in the years after menopause, and weight loss can also affect bone. Systemic estrogen helps protect against early menopausal bone loss, but that does not show that HRT prevents bone changes during GLP-1 treatment, so ask about bone health on its own terms.

What to tell your doctor

If you're considering or already on both HRT and a GLP-1, make sure both of your providers know about the full picture. Specifically:

• Tell your menopause provider about the GLP-1 dose, brand, and when you started
• Tell your GLP-1 prescriber about your HRT regimen, including whether it's transdermal or oral
• If any part of your HRT is taken by mouth, ask whether it should be reviewed when you start the GLP-1 or increase the dose
• If you use systemic estrogen and have a uterus, confirm how your regimen protects the uterine lining
• Ask how to get enough protein and nutrition while your appetite is lower
• Ask about resistance training recommendations and bone health monitoring
• Discuss what happens if you stop either medication

The bigger picture

GLP-1s are not a cure for menopausal weight gain, and HRT isn't either. HRT treats menopause symptoms, and GLP-1 medicines have their own approved uses. Current evidence does not show that the two work together as a combined weight treatment. Both belong inside a wider plan that includes strength training, enough protein, sleep, and realistic expectations about the rate of change.

You deserve a provider who takes the whole picture seriously, understands both therapies, and can help you decide which combination, if any, is right for your body and your goals.

This article is for informational purposes only and does not constitute medical advice. GLP-1 medications have meaningful side effects and are not appropriate for everyone. Always consult with a qualified healthcare provider before starting or combining treatments.

Related: combining HRT and a GLP-1 · how GLP-1s and hormones interact